Point prevalence rates of neurological diseases
| Neurological disease | Male | Female | P value | All | ||||
| Cases (n=922) | Prevalence per 1000 (95% CI) | Cases (n=1470) | Prevalence per 1000 (95% CI) | Cases (N=2392) | Prevalence per 1000 (95% CI) | |||
| Epilepsy | 4 | 4.33 (1.7 to 11.0) | 3 | 2.04 (0.7 to 5.9) | 0.44* | 7 | 2.93 (1.4 to 6.0) | |
| Dementia | 3 | 3.25 (1.1 to 9.6) | 3 | 2.04 (0.7 to 5.9) | 0.68* | 6 | 2.51 (1.1 to 5.5) | |
| Movement disorders | Parkinson’s disease | 7 | 7.59 (3.7 to 15.6) | 3 | 2.04 (0.7 to 5.9) | 0.04†‡ | 10 | 4.18 (2.3 to 7.7) |
| Essential tremors | 10 | 10.8 (5.9 to 19.8) | 4 | 2.72 (1.0 to 6.9) | 14 | 5.85 (3.5 to 9.9) | ||
| Writers’ cramp | – | 1 | 0.68 (0.1 to 3.9) | 1 | 0.42 (0.1 to 2.3) | |||
| Primary headaches | Tension-type headache | 262 | 284.16 (256.0 to 314.2) | 442 | 300.68 (277.8 to 324.6) | 0.249† | 704 | 294.31 (276.4 to 312.9) |
| Migraine | 5 | 5.42 (2.3 to 12.6) | 17 | 11.56 (7.3 to 18.5) | 22 | 9.20 (6.1 to 13.9) | ||
| Cluster headache | 1 | 1.08 (0.2 to 6.1) | 1 | 0.68 (0.1 to 3.9) | 2 | 0.84 (0.2 to 3.0) | ||
| Stroke | 8 | 8.67 (4.4 to 17.1) | 9 | 6.12 (3.2 to 11.6) | 0.469† | 17 | 7.11 (4.4 to 11.3) | |
| Nutritional diseases | Tropical ataxic neuropathy | 14 | 15.18 (9.1 to 25.3) | 25 | 17.00 (11.5 to 25.0) | 0.731† | 39 | 16.3 (11.9 to 22.2) |
| Neurological injuries | Sciatic nerve injuries | 1 | 1.08 (0.2 to 6.1) | 1 | 0.68 (0.1 to 3.9) | 1.000* | 2 | 0.84 (0.2 to 3.0) |
| Neuroinfections and sequelae | Poliomyelitis | 3 | 3.25 (1.1 to 9.6) | 3 | 2.04 (0.7 to 5.9) | 0.681* | 6 | 2.50 (1.1 to 5.5) |
| Others | Unclassified myelopathy | – | 3 | 2.04 (0.7 to 5.9) | 1.000* | 3 | 1.25 (0.5 to 3.7) | |
| Spondylotic myelopathy | 1 | 1.08 (0.2 to 6.1) | – | 1 | 0.42 (0.1 to 2.3) | |||
| Carpal tunnel | – | 1 | 0.68 (0.1 to 3.9) | 1 | 0.42 (0.1 to 2.3) | |||
| Myasthenia gravis | – | 1 | 0.68 (0.1 to 3.9) | 1 | 0.42 (0.1 to 2.3) | |||
| Mental retardation | 3 | 3.25 (1.1 to 9.6) | 2 | 1.36 (0.4 to 5.0) | 0.379* | 5 | 2.09 (0.9 to 4.9) | |
| Medication overuse headache | 1 | 1.08 (0.2 to 6.1) | – | 1 | 0.42 (0.1 to 2.3) | |||
| 842 | 352.0 (333.1 to 352.0) | |||||||
*Fisher’s exact test.
†Pearson’s χ2 test.
‡Statistically significant.